Cannula

COVID-19 Impact on Medical Tubing Market - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, April 30, 2020
Berkshire Hathaway, Lubrizol, Tubing, Cannula, Teleflex, Catheter, Companies, Economy of the United States

The US is projected to be the leading medical tubing market during the forecast period.

Key Points: 
  • The US is projected to be the leading medical tubing market during the forecast period.
  • The growth in the US can be attributed to the rising demand for medical tubing applications such as drug delivery, catheter & cannulas, bulk disposable tubing, and special application.
  • The presence of a robust industrial base, favorable government policies, and large number of established players for medical tubing in the country are strengthening the medical tubing industry in the country.
  • Zeus Industrial Products (US), Saint Gobain Performance Plastics (France), Teleflex (US), Optinova (US), and Lubrizol Corporation (Vesta) (US), among others, are the key players operating in the medical tubing market.

COVID-19 Impact on Medical Tubing Market - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, April 30, 2020
Berkshire Hathaway, Lubrizol, Tubing, Cannula, Teleflex, Catheter, Companies, Economy of the United States

The US is projected to be the leading medical tubing market during the forecast period.

Key Points: 
  • The US is projected to be the leading medical tubing market during the forecast period.
  • The growth in the US can be attributed to the rising demand for medical tubing applications such as drug delivery, catheter & cannulas, bulk disposable tubing, and special application.
  • The presence of a robust industrial base, favorable government policies, and large number of established players for medical tubing in the country are strengthening the medical tubing industry in the country.
  • Zeus Industrial Products (US), Saint Gobain Performance Plastics (France), Teleflex (US), Optinova (US), and Lubrizol Corporation (Vesta) (US), among others, are the key players operating in the medical tubing market.

COVID-19 Impact on Medical Tubing Market - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, April 30, 2020
Berkshire Hathaway, Lubrizol, Tubing, Cannula, Teleflex, Catheter, Companies, Economy of the United States

The US is projected to be the leading medical tubing market during the forecast period.

Key Points: 
  • The US is projected to be the leading medical tubing market during the forecast period.
  • The growth in the US can be attributed to the rising demand for medical tubing applications such as drug delivery, catheter & cannulas, bulk disposable tubing, and special application.
  • The presence of a robust industrial base, favorable government policies, and large number of established players for medical tubing in the country are strengthening the medical tubing industry in the country.
  • Zeus Industrial Products (US), Saint Gobain Performance Plastics (France), Teleflex (US), Optinova (US), and Lubrizol Corporation (Vesta) (US), among others, are the key players operating in the medical tubing market.

LivaNova Bi-Flow Cannula Receives CE Mark for ECMO Applications

Retrieved on: 
Monday, April 27, 2020
Research, Medical devices, Hospitals, Clinical trials, Science, Surgery, Cardiology, Biotechnology, Medical Supplies, FDA, Other Science, Health, Medical equipment, Medicine, Intensive care medicine, Extracorporeal membrane oxygenation, Membrane technology, Cannula, Extracorporeal, Femoral artery, LivaNova, Extracorporeal cardiopulmonary resuscitation, Cardiopulmonary bypass

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Bi-Flow Extracorporeal Membrane Oxygenation (ECMO) cannula earned CE Mark approval for ECMO procedures where femoral artery cannulation can be applied.

Key Points: 
  • LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Bi-Flow Extracorporeal Membrane Oxygenation (ECMO) cannula earned CE Mark approval for ECMO procedures where femoral artery cannulation can be applied.
  • Bi-Flow previously received CE Mark in 2019 for cardiac surgery procedures requiring femoral artery cannulation.
  • We are looking forward to having this cannula so we can treat critically ill patients in an effective way.
  • I see real enthusiasm among clinicians for the availability of Bi-Flow ECMO as a potential solution for this difficult clinical problem.

Asia Pacific High-Flow Nasal Cannula Market (2019 to 2027) - Increasing Chronic Respiratory Disease Across APAC is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, March 23, 2020
Medical devices, Health, Medical equipment, Nasal cannula, Cannula, Apac

The APAC high-flow nasal cannula market is expected to reach US$ 2,536.52 Mn in 2027 from US$ 951.53 Mn in 2018.

Key Points: 
  • The APAC high-flow nasal cannula market is expected to reach US$ 2,536.52 Mn in 2027 from US$ 951.53 Mn in 2018.
  • In 2018, the India high-flow nasal cannula market held the largest share of the APAC high-flow nasal cannula market.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the high-flow nasal cannula market.
  • Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the market, as well as those hindering it.

InventHelp Presents Protector for Nasal Cannula (SOG-354)

Retrieved on: 
Wednesday, February 19, 2020
Medical equipment, Medicine, Clinical medicine, Health, Respiratory therapy, Oxygen, Nasal cannula, Cannula, Oxygen therapy, NC

PITTSBURGH, Feb. 19, 2020 /PRNewswire/ -- "I use oxygen and found a need for a way to protect the nasal ports of my cannula from contamination," said an inventor from Rio Vista, Calif. "That inspired me to invent this handy and convenient protector."

Key Points: 
  • PITTSBURGH, Feb. 19, 2020 /PRNewswire/ -- "I use oxygen and found a need for a way to protect the nasal ports of my cannula from contamination," said an inventor from Rio Vista, Calif. "That inspired me to invent this handy and convenient protector."
  • She developed the OXYGEN CANNULA PROTECTOR, patent pending, to protect a nasal cannula and keeps the nostril ports clean and hygienic.
  • The original design was submitted to the San Diego sales office of InventHelp.
  • 18-SOG-354, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext.

The North America high-flow nasal cannula market is expected to reach US$ 4,261.14 Mn in 2027 from US$ 1,644.50 Mn in 2018

Retrieved on: 
Tuesday, February 18, 2020
Medical equipment, Medicine, Health, Respiratory therapy, Clinical medicine, Heated humidified high-flow therapy, Mechanical ventilation, Cannula, Nasal cannula, Chronic obstructive pulmonary disease, COPD: Journal of Chronic Obstructive Pulmonary Disease

The North America high-flow nasal cannula market is expected to reach US$ 4,261.14 Mn in 2027 from US$ 1,644.50 Mn in 2018.

Key Points: 
  • The North America high-flow nasal cannula market is expected to reach US$ 4,261.14 Mn in 2027 from US$ 1,644.50 Mn in 2018.
  • However, adverse effects or risk of high flow nasal cannula is likely to have a negative impact on the growth of the market in the coming years.
  • In 2018, the US high-flow nasal cannula market held the largest share of the North America high-flow nasal cannula market because it has highest COPD prevalence.
  • Chronic Obstructive Pulmonary Disease segment a largest market share of the high-flow nasal cannula market, by application in 2018.

The European high-flow nasal cannula market is expected to reach US$ 3,298.04 Mn in 2027 from US$ 1,327.65 Mn in 2018

Retrieved on: 
Tuesday, February 18, 2020
Medical equipment, Medicine, Clinical medicine, Health, Heated humidified high-flow therapy, Nasal cannula, Cannula

The European high-flow nasal cannula market is expected to reach US$ 3,298.04 Mn in 2027 from US$ 1,327.65 Mn in 2018.

Key Points: 
  • The European high-flow nasal cannula market is expected to reach US$ 3,298.04 Mn in 2027 from US$ 1,327.65 Mn in 2018.
  • However, side effects associated with high flow nasal cannula is likely to have a negative impact on the growth of the market in the coming years.
  • In 2018, the UK high-flow nasal cannula market held the largest share of the Europe high-flow nasal cannula market.The hospital segment expected to dominate the Europe high-flow nasal cannula market.
  • Chronic Obstructive Pulmonary Disease segment a largest market share of the high-flow nasal cannula market, by application in 2018.

Reduced Inhaler Use is Safe for Infants with Bronchiolitis

Retrieved on: 
Monday, January 13, 2020
Medicine, Medical specialties, Medical equipment, Health, Bronchiolitis, Pediatrics, RTT, Respiratory therapy, Bronchodilator, Nasal cannula, Cannula, Bronchiole

A multidisciplinary team of researchers from Children's Hospital of Philadelphia (CHOP) redesigned the hospital's standard treatment for the infection and reduced albuterol use without compromising care.

Key Points: 
  • A multidisciplinary team of researchers from Children's Hospital of Philadelphia (CHOP) redesigned the hospital's standard treatment for the infection and reduced albuterol use without compromising care.
  • The AAP updated its bronchiolitis guidelines in 2014, recommending against the use of bronchodilators like albuterol in typical patients with bronchiolitis.
  • The team measured patient admission rates, length of stay and revisit rates and found the reduced albuterol use did not impact those metrics.
  • "The next step for improving bronchiolitis care at CHOP is focusing on the use of the high-flow nasal cannula, an emerging therapy for infants with severe bronchiolitis."

John Mack, Medtronic, Minneapolis, named chair of American Heart Association's Twin Cities Board

Retrieved on: 
Monday, November 11, 2019
Medicine, Cardiac surgery, Medtronic, Off-pump coronary artery bypass, Minneapolis, Cannula

MINNEAPOLIS, Nov. 11, 2019 /PRNewswire/ -- John Mack, VP and general manager of Medtronic's Cardiac Surgery business, was elected chair of the American Heart Association's Twin Cities Board, for a two-year term.

Key Points: 
  • MINNEAPOLIS, Nov. 11, 2019 /PRNewswire/ -- John Mack, VP and general manager of Medtronic's Cardiac Surgery business, was elected chair of the American Heart Association's Twin Cities Board, for a two-year term.
  • "We are honored to have John's expertise and leadership to guide us into the future," said Holly Messick, executive director of the American Heart Association in Minnesota.
  • Mack will head up a group of 24other local healthcare professionals and business and community leaders on the Twin Cities Board.
  • At Medtronic, Mack oversees the cardiopulmonary, blood management, cannula, MICS, OpCab, ablation, surgical heart valves and repair businesses.